Pharmaceutical Executive May 21, 2024
In an interview with Pharm Exec Associate Editor Don Tracy, Tala Fakhouri, at Financial Times’ US Pharma and Biotech Summit, Tala Fakhouri, Associate Director for Policy Analysis, FDA, discusses whether the FDA plans on restricting the use of AI and what the future could look like when it comes to machine learning.
PE: Do you see the FDA placing any restrictions on the use of AI and machine learning as times goes on? What may prompt such actions?
Fakhouri: Like I mentioned during the keynote interview, we get asked, does FDA regulate large language models? Are you going to ban generative AI use? My response is that we typically don’t regulate linear regression. We look at the data and the...
Today's Sponsors
Today's Sponsor